The Skin Microbiome and Bioactive Compounds: Mechanisms of Modulation, Dysbiosis, and Dermatological Implications
Molecules · 11.11.2025 · 30 (22) · 4363
DOI: 10.3390/molecules30224363 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 11.11.2025. Verfasst von Katarzyna Wojciechowska und 1 weiteren Autor:innen. Beteiligte Einrichtung: Chair and Department of Applied Pharmacy, Medical University of Lublin, Chodźki 1, 20-093 Lublin, Poland. Hauptthemen laut MEDLINE: Skin, Dysbiosis, Microbiota. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 275 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Maintaining the balance between the host and commensal microorganisms is essential for skin health. The disruption of this equilibrium (dysbiosis) can contribute to inflammatory and infectious diseases and accelerate skin aging. Dysbiosis also accompanies skin cancers and may influence their progression. Causes of dysbiosis include exogenous factors such as cosmetics, UV radiation, pollution, and diet, as well as endogenous factors like stress, hormonal imbalances, and aging. Standard antibacterial treatments often eliminate beneficial microbes and may exacerbate conditions. Consequently, there is growing interest in alternative strategies—notably natural plant- and animal-derived products—that can modulate the skin microbiome more selectively and gently. This review presents current knowledge on skin microbiome physiology and dysbiosis and discusses natural compounds and microbiome-based therapies (probiotics, prebiotics, postbiotics) that modulate the skin microbiota. Unlike prior reviews, we provide a comparative perspective on emerging compound classes (e.g., peptides, lipids) and integrate the skin–gut axis concept into the framework, highlighting mechanistic insights at molecular and clinical levels. Our synthesis emphasizes distinct modes of action and evidence levels—from in vitro mechanisms to clinical outcomes—and offers guidance for formulation of microbiome-compatible products.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chair and Department of Applied Pharmacy, Medical University of Lublin, Chodźki 1, 20-093 Lublin, Poland.
- Department of Pharmaceutical Botany, Medical University of Lublin, Chodźki 1, 20-093 Lublin, Poland.
ORCID-Profile: Katarzyna Wojciechowska, Katarzyna Dos Santos Szewczyk
Zitieren
APA
Wojciechowska, K., & Dos Santos Szewczyk, K. (2025). The Skin Microbiome and Bioactive Compounds: Mechanisms of Modulation, Dysbiosis, and Dermatological Implications. Molecules, 30(22), 4363. https://doi.org/10.3390/molecules30224363
Vancouver
Wojciechowska K, Dos Santos Szewczyk K. The Skin Microbiome and Bioactive Compounds: Mechanisms of Modulation, Dysbiosis, and Dermatological Implications. Molecules. 2025;30(22):4363. doi:10.3390/molecules30224363
BibTeX
@article{Wojciechowska2025,
author = {Wojciechowska, Katarzyna and Dos Santos Szewczyk, Katarzyna},
title = {The Skin Microbiome and Bioactive Compounds: Mechanisms of Modulation, Dysbiosis, and Dermatological Implications},
journal = {Molecules},
year = {2025},
volume = {30},
number = {22},
pages = {4363},
doi = {10.3390/molecules30224363}
}
EUVIMED